Ignite Creation Date:
2024-07-17 @ 11:17 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499454
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-05
Brief Title:
Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel Instrument
Sponsor:
Ruby Robotics Inc
Organization:
Ruby Robotics Inc
Study Overview
Official Title:
Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel Instrument
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to learn whether the Ruby Robotics system enables pathologists to determine whether a bronchoscopic biopsy sample is adequate for diagnosis The main question it aims to answer is
- Are pathologists evaluations of Ruby digital images concordant with their evaluations of manually created rapid on-site evaluation slides
- Are pathologists evaluations of Ruby digital images concordant with their evaluations of manually created rapid on-site evaluation slides
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: